The chronic release of ROS, linked to the development of left ventricular hypertrophy and heart failure progression, increases TGF‐β–mediated activation of Smad2/3 to indicate a potentially important role for ROS in TGF‐β–stimulated conversion of fibroblast to myofibroblast phenotype.29 The gene discussed is TGFB1; the disease is heart failure.